Virus replication and virion export in X-deficient hepatitis B virus transgenic mice

References

1. Blum H. E., Zhang Z. S., Galun E., von-Weizsacker F., Garner B., Liang T. J., Wands J. R. 1992; Hepatitis B virus X protein is not central to the viral life cycle in vitro. Journal of Virology 66:1223–1227
   [Google Scholar]
2. Chen H., Kaneko S., Girones R., Anderson R., Hornbuckle W., Tennant B., Cote P., Gerin J., Purcell R., Miller R. 1993; The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. Journal of Virology 67:1218–1226
   [Google Scholar]
3. Colgrove R., Simon G., Ganem D. 1989; Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. Journal of Virology 63:4019–4026
   [Google Scholar]
4. Dandri M., Schirmacher P., Rogler C. E. 1996; Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. Journal of Virology 70:5246–5254
   [Google Scholar]
5. Guidotti L. G., Matzke B., Schaller H., Chisari F. V. 1995; High-level hepatitis B virus replication in transgenic mice. Journal of Virology 69:6158–6169
   [Google Scholar]
6. Guidotti L. G., Matzke B., Pasquinelli C., Shoenberger J. M., Rogler C. E., Chisari F. V. 1996; The hepatitis B virus precore protein inhibits HBV replication in transgenic mice. Journal of Virology 70:7056–7061
   [Google Scholar]
7. Guo W., Chen M., Yen T. S., Ou J. H. 1993; Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Molecular and Cellular Biology 13:443–448
   [Google Scholar]
8. Hogan B., Beddington R., Costantini F., Lacy E. 1994 Manipulating the Mouse Embryo: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
   [Google Scholar]
9. Hsu S., Raine L., Fanger H. 1981; Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 29:577–580
   [Google Scholar]
10. Kim C. M., Koike K., Saito I., Miyamura T., Jay G. 1991; HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
    [Google Scholar]
11. Koike K., Shirakata Y., Yaginuma K., Arii M., Takada S., Nakamura I., Hayashi Y., Kawada M., Kobayashi M. 1989; Oncogenic potential of hepatitis B virus. Molecular Biology and Medicine 6:151–160
    [Google Scholar]
12. Lee T. H., Finegold M. J., Shen R. F., DeMayo J. L., Woo S. L., Butel J. S. 1990; Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 64:5939–5947
    [Google Scholar]
13. Levrero M., Stemler M., Pasquinelli C., Alberti A., Jean-Jean O., Franco A., Balsano C., Diop D., Brechot C., Melegari M. and others 1991; Significance of anti-HBx antibodies in hepatitis B virus infection. Hepatology 13:143–149
    [Google Scholar]
14. Madden C. R., Finegold M. J., Slagle B. L. 2001; Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. Journal of Virology 75:3851–3858
    [Google Scholar]
15. Murakami S. 1999; Hepatitis B virus X protein: structure, function and biology. Intervirology 42:81–99
    [Google Scholar]
16. Nassal M. 1992; The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. Journal of Virology 66:4107–4116
    [Google Scholar]
17. Pfaff E., Salfeld J., Gmelin K., Schaller H., Theilmann L. 1987; Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 158:456–460
    [Google Scholar]
18. Reifenberg K., Löhler J., Pudollek H. P., Schmitteckert E., Spindler G., Köck J., Schlicht H. J. 1997; Long term expression of the hepatitis B virus core- e- and X-proteins does not cause organ pathology in transgenic mice. Journal of Hepatology 26:119–130
    [Google Scholar]
19. Reifenberg K., Wilts H., Löhler J., Nusser P., Hanano R., Guidotti L. G., Chisari F. V., Schlicht H. J. 1999; The hepatitis B virus X-protein transactivates viral core gene expression in vivo. Journal of Virology 73:10399–10405
    [Google Scholar]
20. Rossner M. 1992; The hepatitis B virus x-gene product: a promiscuous transcriptional activator. Journal of Medical Virology 36:101–117
    [Google Scholar]
21. Schlicht H. J., Schaller H. 1989; The secretory core protein of human hepatitis B virus is expressed on the cell surface. Journal of Virology 63:5399–5404
    [Google Scholar]
22. Spandau D. F., Lee C. H. 1988; Trans-activation of viral enhancers by the hepatitis B virus X protein. Journal of Virology 62:427–434
    [Google Scholar]
23. Su Q., Schroder C. H., Hofmann W. J., Otto G., Pichlmayr R., Bannasch P. 1998; Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27:1109–1120
    [Google Scholar]
24. Yaginuma K., Shirakata Y., Kobayashi M., Koike K. 1987; Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proceedings of the National Academy of Sciences, USA 84:2678–2682
    [Google Scholar]
25. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3:169–177
    [Google Scholar]
26. Zoulim F., Saputelli J., Seeger C. 1994; Woodchuck hepatitis virus X protein is required for viral infection in vivo. Journal of Virology 68:2026–2030
    [Google Scholar]